{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:06:23Z","timestamp":1791050783158,"version":"4.1.0"},"reference-count":114,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1529-8019.2008.00218.x","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T14:56:35Z","timestamp":1223304995000},"page":"362-375","source":"Crossref","is-referenced-by-count":7,"title":["Metabolic syndrome"],"prefix":"10.1155","volume":"21","author":[{"given":"Lillian F","family":"Lien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Guyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB1","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.291.23.2847","article-title":"Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002","volume":"291","author":"Hedley","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.288.14.1723","article-title":"Prevalence and trends in obesity among US adults, 1999-2000","volume":"288","author":"Flegal","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/j.1550-8528.1997.tb00575.x","article-title":"Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994)","volume":"5","author":"Kuczmarski","year":"1997","journal-title":"Obes Res"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ajcn\/72.5.1074","article-title":"Criteria for definition of overweight in transition: background and recommendations for the United States","volume":"72","author":"Kuczmarski","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM199908053410607","article-title":"Guidelines for healthy weight","volume":"341","author":"Willett","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB7","first-page":"985","article-title":"State-specific prevalence of obesity among adults\u00a0-\u00a0United States, 2005","volume":"55","year":"2006","unstructured":"7.State-specific prevalence of obesity among adults\u00a0-\u00a0United States, 2005. MMWR Morb Mortal Wkly Rep 2006: 55: 985-988.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.293.15.1861","article-title":"Excess deaths associated with underweight, overweight, and obesity","volume":"293","author":"Flegal","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.293.3.293","article-title":"Correction: actual causes of death in the United States, 2000","volume":"293","author":"Mokdad","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2105\/AJPH.2005.068874","article-title":"Gender and the burden of disease attributable to obesity","volume":"96","author":"Muennig","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMsr043743","article-title":"A potential decline in life expectancy in the United States in the 21st century","volume":"352","author":"Olshansky","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old","volume":"355","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB15","doi-asserted-by":"crossref","first-page":"419S","DOI":"10.1093\/ajcn\/63.3.419","article-title":"Effect of weight on cardiovascular disease","volume":"63","author":"Kannel","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.295.2.190","article-title":"Midlife body mass index and hospitalization and mortality in older age","volume":"295","author":"Yan","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB17","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2004.07.013","article-title":"Metabolic syndrome: definition, pathophysiology, and mechanisms","volume":"149","author":"Miranda","year":"2005","journal-title":"Am Heart J"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2004.03.004","article-title":"Prevalence of the metabolic syndrome in US populations","volume":"33","author":"Ford","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/01.CIR.0000088845.17586.EC","article-title":"Epidemic obesity and the metabolic syndrome","volume":"108","author":"Haffner","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u00a0-\u00a0a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4158\/EP.9.S2.5","article-title":"American College of Endocrinology position statement on the insulin resistance syndrome","volume":"9","author":"Einhorn","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB26","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","article-title":"Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American heart association council on nutrition, physical activity, and metabolism: endorsed by the american college of cardiology foundation","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB27","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","unstructured":"27.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001: 285: 2486-2497.","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB28","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB29","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/diacare.27.11.2689","article-title":"Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study","volume":"27","author":"Bruno","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB30","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2337\/diacare.27.11.2676","article-title":"Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and\/or cardiovascular disease?","volume":"27","author":"Stern","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc05-2307","article-title":"Does the metabolic syndrome exist?","volume":"29","author":"Grundy","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ecl.2004.03.007","article-title":"Hypertension, insulin resistance, and the metabolic syndrome","volume":"33","author":"Natali","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB33","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1210\/jc.2005-0799","article-title":"The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients","volume":"90","author":"Saely","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehm582","article-title":"Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm","volume":"29","author":"Wassink","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archinte.166.1.106","article-title":"Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study","volume":"166","author":"Najarian","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2006.06.029","article-title":"Polycystic ovary syndrome: diagnosis and treatment","volume":"120","author":"Setji","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB42","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB43","unstructured":"43.International Diabetes Federation (IDF). The IDF consensus worldwide definition of the metabolic syndrome. In: http:\/\/www.idf.org\/metabolic_syndrome. Brussels, 2006."},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB44","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.mcna.2007.06.004","article-title":"The metabolic syndrome: how to approach differing definitions","volume":"91","author":"Pi-Sunyer","year":"2007","journal-title":"Med Clin North Am"},{"issue":"Suppl. 1","key":"10.1111\/j.1529-8019.2008.00218.x-BIB45","first-page":"S4","article-title":"Standards of medical care in diabetes\u00a0-\u00a02006","volume":"29","year":"2006","unstructured":"45.Standards of medical care in diabetes\u00a0-\u00a02006. Diabetes Care 2006: 29(Suppl. 1): S4-S42.","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB46","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/en.2003-0580","article-title":"Minireview: the adipocyte\u00a0-\u00a0at the crossroads of energy homeostasis, inflammation, and atherosclerosis","volume":"144","author":"Rajala","year":"2003","journal-title":"Endocrinology"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/er.2006-0033","article-title":"Adipose tissue-derived factors: impact on health and disease","volume":"27","author":"Trujillo","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","article-title":"Leptin signaling in the central nervous system and the periphery","volume":"59","author":"Bjorbaek","year":"2004","journal-title":"Recent Prog Horm Res"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB49","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB50","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0010045","article-title":"An inflammatory cascade leading to hyperresistinemia in humans","volume":"1","author":"Lehrke","year":"2004","journal-title":"PLoS Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI200525102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB53","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB54","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/oby.2003.144","article-title":"Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance","volume":"11","author":"Monzillo","year":"2003","journal-title":"Obes Res"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB55","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1210\/jc.2004-1011","article-title":"Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects","volume":"90","author":"O\u2019Brien","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","article-title":"Fuel selection in human skeletal muscle in insulin resistance: a reexamination","volume":"49","author":"Kelley","year":"2000","journal-title":"Diabetes"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB57","doi-asserted-by":"crossref","first-page":"E1772","DOI":"10.1152\/ajpendo.00158.2007","article-title":"Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle","volume":"293","author":"Levin","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2007.10.033","article-title":"Small dense LDL particles and metabolic syndrome in a sample of middle-aged women. Findings from Progetto Atena","volume":"388","author":"Gentile","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.ATV.16.1.4","article-title":"Development of the lipid-rich core in human atherosclerosis","volume":"16","author":"Guyton","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB60","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/01.ATV.13.6.842","article-title":"Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations","volume":"13","author":"Ginsberg","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"Suppl. 3","key":"10.1111\/j.1529-8019.2008.00218.x-BIB61","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/diab.45.3.S27","article-title":"Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels","volume":"45","author":"Ginsberg","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB62","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB63","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.ATV.17.6.1114","article-title":"Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study","volume":"17","author":"Jeppesen","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 1","key":"10.1111\/j.1529-8019.2008.00218.x-BIB64","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1038\/oby.2006.281","article-title":"Metabolic syndrome: focus on dyslipidemia","volume":"14","author":"Ginsberg","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB67","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diacare.24.3.588","article-title":"Recent advances in our understanding of insulin action and insulin resistance","volume":"24","author":"Le Roith","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB69","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1047-2797(03)00006-1","article-title":"Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics","volume":"13","author":"Svetkey","year":"2003","journal-title":"Ann Epidemiol"},{"issue":"Suppl. 1","key":"10.1111\/j.1529-8019.2008.00218.x-BIB70","first-page":"S43","article-title":"Interactions between insulin and sodium homeostasis in essential hypertension","volume":"307","author":"Semplicini","year":"1994","journal-title":"Am J Med Sci"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2362.1999.00445.x","article-title":"Salt sensitivity correlates positively with insulin sensitivity in healthy volunteers","volume":"29","author":"ter Maaten","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0895-7061(01)02191-4","article-title":"Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension","volume":"14","author":"Higashi","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB73","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.1993.00410050036006","article-title":"Blood pressure, systolic and diastolic, and cardiovascular risks. US population data","volume":"153","author":"Stamler","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2004.07.012","article-title":"Metabolic syndrome: evaluation of pathological and therapeutic outcomes","volume":"149","author":"Miranda","year":"2005","journal-title":"Am Heart J"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB75","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0021-9150(73)90034-8","article-title":"Studies of the mechanisms of carbohydrate-induced lipaemia in normal man","volume":"17","author":"Mancini","year":"1973","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jcem-42-4-729","article-title":"Induction of hypertriglyceridemia by a low-fat diet","volume":"42","author":"Ginsberg","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB77","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/HYPERTENSIONAHA.107.089458","article-title":"Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome","volume":"50","author":"Lien","year":"2007","journal-title":"Hypertension"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB78","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.107.716159","article-title":"Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study","volume":"117","author":"Lutsey","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB79","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2006-2384","article-title":"Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects","volume":"92","author":"Sato","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB80","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/dc07-0048","article-title":"Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial","volume":"30","author":"Pi-Sunyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB81","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.288.15.1882","article-title":"Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program","volume":"288","author":"Whelton","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB82","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB83","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/ajcn\/86.4.1193","article-title":"The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome","volume":"86","author":"Fogli-Cawley","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB84","unstructured":"84.US Department of Health and Human Services and the US Department of Agriculture. Dietary Guidelines for Americans 2005. http:\/\/www.healthierus.gov, 2005."},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB85","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-142-8-200504190-00009","article-title":"The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial","volume":"142","author":"Orchard","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB86","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2337\/diacare.28.12.2823","article-title":"Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome","volume":"28","author":"Azadbakht","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB87","first-page":"2083","article-title":"Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial","volume":"289","author":"Appel","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.jhh.1001770","article-title":"Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age","volume":"19","author":"Svetkey","year":"2005","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB89","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ahj.2007.12.012","article-title":"Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome","volume":"155","author":"Rosenson","year":"2008","journal-title":"Am Heart J"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB90","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2007-0854","article-title":"Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome","volume":"93","author":"Ooi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB92","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB93","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/dc07-1452","article-title":"Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"31","author":"Black","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB94","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinternmed.2007.66","article-title":"Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"168","author":"Wright","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB95","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1055\/s-2007-993156","article-title":"Effects of spironolactone on glucose transport and interleukin-6 secretion in adipose cells of women","volume":"39","author":"Corbould","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB96","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","article-title":"Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress","volume":"50","author":"Nagase","year":"2007","journal-title":"Hypertension"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB97","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB98","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","article-title":"Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension","volume":"13","author":"Frey","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB99","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.mcna.2004.04.002","article-title":"In-hospital management of type 2 diabetes mellitus","volume":"88","author":"Lien","year":"2004","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB101","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0025-7125(05)70023-7","article-title":"Treatment of type 2 diabetes mellitus","volume":"82","author":"Feinglos","year":"1998","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB102","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.mcna.2007.06.013","article-title":"Medical therapy for obesity\u00a0-\u00a0current status and future hopes","volume":"91","author":"Bray","year":"2007","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB104","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB106","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc07-0233","article-title":"Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications","volume":"30","author":"Ahren","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB107","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis","volume":"298","author":"Amori","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11892-007-0060-0","article-title":"Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity","volume":"7","author":"Green","year":"2007","journal-title":"Curr Diab Rep"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB109","first-page":"1831","article-title":"Therapies for diabetes: pramlintide and exenatide","volume":"75","author":"Jones","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-146-7-200704030-00003","article-title":"The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial","volume":"146","author":"Zinman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-146-7-200704030-00009","article-title":"Exenatide in combination therapy: small study, big market, and many unanswered questions","volume":"146","author":"Malozowski","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/dc08-9016","article-title":"Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB113","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacologic treatment of obesity","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2008.00218.x-BIB114","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-142-7-200504050-00011","article-title":"Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians","volume":"142","author":"Snow","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2008.00218.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2008.00218.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:57:07Z","timestamp":1671818227000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2008.00218.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2008.00218.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}